Ketorolac Effects on Post-operative Pain and Lumbar Fusion
ConditionLumbar Spinal Fusion
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-85
SponsorUniversity of Maryland St. Joseph Medical Center
About this trial
A double blind prospective randomized trial of IV ketorolac vs. placebo in management of patients undergoing lumbar one or two level spinal fusions.
Eligibility criteria
Qualifiers
18-85 years old (inclusive)
Elective posterior lumbar instrumented fusion
One or two level fusion
Consent to participate in study and willing to adhere to study follow up
Disqualifiers
< 18 or > 85 years old
History of renal failure, dialysis, or creatinine over 1.50 mg/dl
Active or recent smoker (active within past 6 months)
Revision surgery
Trial design
Treatments tested in this trial
- Ketorolac Tromethamine
- Placebo
Treatment groups
140 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Maryland St. Joseph Medical Center
Lead sponsor
Medical Metrics Diagnostics, Inc
Collaborator
Source ClinicalTrials.gov